8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Dec 2, 2024 · 1y ago · Accession 0000950170-24-132302
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 8-K
- Filing date
- Dec 2, 2024
- Report date
- Dec 2, 2024
- Document
- janx-20241202.htm
- Size
- 12.9 MB